Alexion Pharmaceuticals, Inc.

NASDAQ: ALXN
$112.02
-$0.41 (-0.4%)
Closing price September 24, 2020
The August 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Practically any biotech company attempting almost anything COVID-19 related has seen massive gains. However, there is likely more to come for the rest of the year and into next year. These five...
The August 14 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The July 31 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
24/7 has compiled a few biopharmaceutical names that have lagged the markets and recently have reported earnings. In a sense, the fundamentals have shown some light on these stocks, that they may be...
Investors have flocked to the dividends of Big Pharma and flocked to the limitless upside of major biotech outfits for years. Valuations are no longer considered high for these two healthcare...
The July 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Earnings season is in full swing, and we have put together a preview of some of the world’s largest players in the health care sector reporting this coming week.
The June 30 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks were mixed.
The June 15 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
The May 29 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks decreased.
Friday's top analyst upgrades and downgrades included Alexion Pharmaceuticals, Ciena, Dell Technologies, Dollar General, Dollar Tree, Marvell Technology, PPL, Republic Services, Tesla, VMware and...
The May 15 short interest data has been compared with the previous report, and short interest moves in these selected biotech stocks was mixed.
The April 30 short interest data has been compared with the previous report, and short interest in most of these selected biotech stocks increased.
Portola Pharmaceuticals shares more than doubled on Tuesday after the company announced that it would be acquired by Alexion Pharmaceuticals.